Covered recipient · General Payments record
MICHAEL E SAYERS
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2023
$2,720.08
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $270.19 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $139.23 | 11 |
| GlaxoSmithKline, LLC. | $49.72 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.97 | 1 |
| Genentech USA, Inc. | $22.39 | 1 |
| Amgen Inc. | $15.58 | 1 |
| PFIZER INC. | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $7.33 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842115 | CMS |
| AbbVie Inc. | $7.55 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842119 | CMS |
| AbbVie Inc. | $20.01 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842123 | CMS |
| AbbVie Inc. | $10.92 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842127 | CMS |
| AbbVie Inc. | $9.10 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842131 | CMS |
| AbbVie Inc. | $8.99 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842135 | CMS |
| AbbVie Inc. | $18.68 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842139 | CMS |
| AbbVie Inc. | $15.41 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842143 | CMS |
| AbbVie Inc. | $9.23 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842147 | CMS |
| AbbVie Inc. | $21.40 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842151 | CMS |
| AbbVie Inc. | $10.61 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998842155 | CMS |
| Amgen Inc. | $15.58 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020639027 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.97 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997139893 | CMS |
| Genentech USA, Inc. | $22.39 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040468339 | CMS |
| GlaxoSmithKline, LLC. | $13.89 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003472745 | CMS |
| GlaxoSmithKline, LLC. | $17.31 | 04/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003472741 | CMS |
| GlaxoSmithKline, LLC. | $18.52 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003472749 | CMS |
| PFIZER INC. | $14.30 | 11/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050661939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.